Orientals have unique genetic polymorphisms in ethanol metabolizing enzymes, such as alcohol dehydrogenase-2 (ADH2), aldehyde dehydrogenase-2 (ALDH2) and cytochrome P450-2E1 (CYP2E1). Of the three studies conducted to clarify the influence of ALDH2 genotypes on sensitivity to the pressor effects of alcohol in Japanese, only one was suggested, though indirectly, higher sensitivity in drinkers having the genotype of inactive ALDH2. This discrepancy prompted us to determine ADH2, ALDH2 and CYP2E1 genotypes in the genomic DNA extracted from white blood cells of 855 healthy middle-aged Japanese men, and to analyse the associations with the alcohol-blood pressure (BP) relationship. No marked differences were found in the relationship among the genotypes of ALDH2, although the subjects with intact ALDH2 showed a slightly higher
Introduction
A large number of Oriental people including Japanese have unique alleles of ethanol-metabolizing enzyme genes, such as *2 allele of alcohol dehydrogenase-2 (ADH2*2), *2 allele of aldehyde dehydrogenase-2 (ALDH2*2), and c2 allele of cytochrome P450-2E1 (CYP2E1). 1 All these alleles are quite rare or almost absent in Caucasians and cause a considerable variation in the enzyme activities in Orientals. Of these, the deficit in the activity of ALDH2, which converts acetaldehyde into acetic acid, due to the ALDH2*2 allele exerts a strong influence on drinking behaviour in Orientals. The ALDH2*2 allele encodes an inactive subunit protein of the enzyme. The enzyme of ALDH2 consists of four subunit proteins, and will show loss of the activity when even one inactive subunit protein is included. People homozygous for ALDH2*2 allele (ALDH2*2/2) thus do not have any activity at all, but even those heterozygous for the normal and variant alleles (ALDH2*1/2) show only 1/16 of the activity of those homozygous for normal ALDH2*1 alleles (ALDH2*1/1). Nearly one half of Japanese have the ALDH2*2 allele and cannot convert acetaldehyde into acetic aid rapidly. Since acetaldehyde accumulates in the blood causing uncomfortable symptoms of facial flushing, palpitation and headache even when a small amount of alcohol is consumed, greater alcohol consumption is often limited. 2 It can be assumed therefore that ALDH2 genotypes may associate with individual differences in sensitivity to alcohol toxicity including the pressor effect. As far as we know, three studies have so far been conducted in Japanese men aiming to clarify the influence of the genetic difference in ALDH2 on the alcohol and blood pressure (BP) relationship, [3] [4] [5] but two of them showed negative results: one evaluating phenotypes of the subjects using an alcohol-patch test 3 and one by genotypes of the genomic DNA extracted from white blood cells. 4 Only one study conducted by Itoh et al 5 reported findings suggestive of a significant association of the variant allele of ALDH2*2 with a higher BP in alcohol consumers. Namely, a significant association between facial flushing response and the presence of ALDH2*2 allele was observed in 53 individuals, and in a subsequent large-scale study on 1000 or more individuals, drinkers manifesting the flushing response showed a higher prevalence of hypertension than those who did not. Itoh et al 5 thus speculated that people who have ALDH2*2 allele are more sensitive to the pressor effect of alcohol, and referred to the pathogenetic role of acetaldehyde in BP elevation in drinkers, which is consistent with the hypothesis proposed by Vasdev et al [6] [7] [8] [9] from the results of studies on rats fed ethanol-water solution.
The study of Itoh et al 5 however, showed only an indirect association of ALDH2 genotypes with higher BP in alcohol consumers, and it contradicted the negative findings in the previous two studies. 2, 3 In addition, the genetic differences in the other ethanol metabolizing enzymes in Japanese, such as ADH2 and CYP2E1, have not been fully evaluated as related to BP elevation in drinkers, although both of them have been suggested to play a role in the development of alcoholic psychiatric [10] [11] [12] and liver diseases. 13, 14 In the present study, therefore, we evaluated the association of genetic polymorphisms in ALDH2, ADH2 and CYP2E1 with BP in alcohol consumers by determining all the genotypes in a middle-aged male occupational population in Japan.
Subjects and methods
The study subjects were recruited from male workers in an electronic parts-producing factory aged from 35 to 59 years (43.1 ± 6.4 years, mean ± s.d.), who participated in an annual health check-up programme conducted in this factory. Written informed consent was obtained from 855 participants. They comprised 95.2% of the total 898 male employees of this age group in the factory. Forty workers did not participate in the health checks and three refused to be involved in this study.
Information concerning usual alcohol consumption, such as frequency of drinking, types of alcoholic beverages and the amount consumed at one time during the preceding 1-year period, was obtained by a questionnaire and then confirmed by an experienced nurse in interview. Drinking patterns were then classified into five categories according to the drinking frequency and the average amount per day. Non-drinker (ND) referred to teetotallers and abstainers and the subjects who drink only 10 ml or less of alcohol per time less than once a month; chance drinker (CD) referred to those who drink more often but twice a week or less. Those who drink 3 days or more a week were defined as habitual drinkers, in whom light (LD), moderate (MD) and excessive drinkers (ED) were subdivided by two cut-off points, 60 ml and 90 ml of ethanol consumed per day on average. At the same time, information about medical histories including diagnosis and treatment of hypertension was obtained by a questionnaire and confirmed in the interview.
Height and weight of the subjects were measured in the morning after fasting for 12 h or longer with shoes and jackets off, and body mass index (BMI: kg/m 2 ) was calculated. Systolic and diastolic blood pressures (SBP and DBP: mm Hg) were measured with a sphygmomanometer in the sitting position after resting on a chair for 5 min or longer. Diastolic BP was determined at the Korotkoff 5th sound. The fasting venous blood samples were analysed for haematological parameters including erythrocyte haemoglobin concentration (Hb) and the mean corpuscular volume (MCV) using an automatic analyser (Technicon H2 system, Bayer-Sankyo, Japan), and for serum biochemical parameters of gammaglutamyl transferase (GGT), and triglycerides (TG), total cholesterol (Tch), HDL-cholesterol (HDLc), and uric acid (UA) using an automatic analyzer (Hitachi 7450, Hitachi, Japan).
Genotypes of ALDH2, ADH2 and CYP2E1 were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods using the genomic DNA extracted from white blood cells according to the previously described methods. [15] [16] [17] Briefly, the genomic DNA samples were obtained from the white blood cells with a DNA Extractor WB Kit (Wako, Japan), and then amplified by PCR (Perkin-Elmer 2400, USA) for each of ALDH2, ADH2 and CYP2E1 loci. The PCR products were digested into the DNA fragments by specific restrictive endonuclease for the enzymes, ie., MobII (Wako, Japan) for ALDH2, MaeIII (Boehringer, Germany) for ADH2, and Rsa1 and Pst1 (Wako, Japan) for CYP2E1. The subjects were then categorised into three genotypes for each of ALDH2, ADH2 and CYP2E1 by the results of gel electrophoresis of the DNA fragments.
The least square means of systolic and diastolic BP and those of haematological and biochemical parameters were calculated being adjusted for age and BMI in the five drinking categories and in the five serum GGT levels of less than 20 U/l, 20-39, 40-59, 60-99, and 100 U/l or above, and the means in each of the five categories were compared to confirm BP elevations with increases in alcohol consumption in this population by analysis of variance (ANOVA). These analyses were performed using a generalised linear model procedure included in an SAS programme package for a personal computer (Pc-SAS: SAS Institute, USA).
The relationships between increases in the amount of alcohol consumed and elevations of systolic and diastolic BP were then illustrated in the subjects having the three genotypes in each of ALDH2, ADH2 and CYP2E1 genes. The significance of the effects of age, BMI, alcohol consumption and that of the biologically dominant allele of the gene and the interactive effect of the allele and alcohol consumption on BP levels were tested in each of the enzyme genes by multivariate regression analyses.
Finally, the independent effects of the dominant alleles of ALDH2, ADH2 and CYP2E1 genes and the interactive effects of ALDH2 and ADH2 genes and of ALDH2 and CYP2E1 genes on BP elevations with increases in alcohol consumption as well as the effects of age and BMI were tested for their significance. These statistical analyses were also performed using a generalised linear model procedure in an SAS programme package. Statistical significance was defined as P Ͻ 0.05. P Ͻ 0.01 was regarded as high significance and 0.05 р P Ͻ 0.10 as borderline significance.
Results
The means, standard deviations and ranges of height (cm) and body weight (kg) of the 855 male subjects were 169.5, 5.4, 147-186.6, and 69.4, 9.6, 44.5-109.2, respectively. Those of BMI were 24.1, 3.0, 16.1-36.9. In this population, 27 subjects reported being under treatment for hypertension with medicines. In addition, 219 subjects showed BP у140/90 mm Hg at the health checks-up including 105 with BP у160/95 mm Hg. The total 246 subjects were defined as hypertensives, with the prevalence in this population of 28.8%. The distribution of the hypertensive subjects according to the drinking categories is illustrated in Figure 1 . Hypertension was increased with increases in alcohol consumption levels. The prevalence of 35.6% in the subjects consuming 60 to 89 ml of alcohol per day (MD) was 1.7-fold and 40.1% in those consuming 90 ml or more alcohol (ED) was 1.9-fold higher than 20.6% in the non-drinkers. These ratios were basically consistent with the observations in previous epidemiological studies. 18 Excluding the 27 subjects under treatment for hypertension with medicines, least square means of BP and biochemical parameters in the 105 ND, 177 Table 1 with the standard errors. Geometric mean and geometric standard error were obtained for serum GGT and TG. As shown in the table, the results of ANOVA showed significant increases in the means of systolic and diastolic BP, serum GGT, TG, HDLc and erythrocyte MCV with the elevations of alcohol consumption levels. Serum Tch, UA and erythrocyte Hb did not show significant differences among the drinking categories. On the other hand, the analyses on the associations between the changes in those parameters and increases in serum GGT levels in the subjects showed significant elevations in all the means with the elevations of serum GGT ( Table 2) .
The results of genotyping of ALDH2, ADH2 and CYP2E1 in the subjects were as follows: 499 (58.4%) in ALDH2*1/1, 307 (35.9%) in ALDH2*1/2 and 49 (5.7%) in ALDH2*2/2; 33 (3.9%) in ADH2*1/1, 310 (36.3%) in ADH2*1/2 and 512 (59.8%) in ADH2* 2/2; 507 (59.3%) in c1/c1, 310 (36.3%) in c1/c2 and 38 (4.4%) in c2/c2. The distributions of the three enzyme genotypes were independent of each other, and basically in accordance with the previous studies in Japanese 11, 12, 19, 20 and with Hardy-Weinberg equilibrium. 21 The least square means and standard errors of systolic and diastolic BP being adjusted for age and BMI in the different alcohol consumption levels were calculated in the subjects having the different genotypes of ALDH2 (Table 3) , ADH2 (Table 4 ) and CYP2E1 ( Table 5 ). As shown in the tables, BP seemed somewhat higher in the subjects having ALDH2*1/1 genotype and those having c2/c2 of CYP2E1 genotype in comparison with the other genotypes particularly in the moderate and excessive drinkers.
Although not shown in the tables, regression analyses on the determinants of BP including age, BMI, and the average volume of alcohol consumed per day as continuous variables, and the two genotypes in each enzyme as a categorical variable, and the interaction of the genotype and alcohol consumption, produced the following results: in addition to highly significant contributions of age, BMI and alcohol consumption, a borderline contribution (P = 0.051) of ALDH2*1/1 genotype to the elevation of diastolic BP, and a borderline (P = 0.099) and a weak significant (P = 0.022) contribution of c2 allele of CYP2E1 to elevations of systolic and diastolic BP respectively were observed, while there was no significant effect of the interaction of the genotypes and alcohol consumption on BP. In these analyses, the enzyme genotypes were divided into two groups each, such as those having ALDH2*2 allele and those with ALDH2*1/1, and those having ADH2*2 allele and those with ADH2* 1/1, and those having c2 allele and those with c1/c1 of CYP2E1, considering the biologically dominant effect of the alleles on the enzyme activities.
Since ALDH2 genotype exerts an overwhelming influence on drinking behaviour in Japanese and thus may have affected the contributions of ADH2 and CYP2E1 genotypes to the alcohol and BP relationship, and an interactive effect of ALDH2*1/1 genotype and c2 allele of CYP2E1 gene on promoting alcohol consumption was observed in our previous study, 20 further analyses were performed on the overall contributions of the independent effects of ALDH2, ADH2 and CYP2E1 and interactive effect of ALDH2 and ADH2 and that of ALDH2 and CYP2E1 genotypes on the alcohol and BP relationship ( Table 6 ). As shown in the table, no significant contributions of the independent and interactive effects of the genotypes were found to systolic BP levels although age, BMI and alcohol consumption Interactive effects of the two enzyme genotypes.
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were strongly related to it. However, a borderline contribution of ALDH2*1/1 genotype and a weak but significant contribution of c2 allele of CYP2E1 to the elevation of diastolic BP were detected as well as those of age, BMI and alcohol consumption.
Discussion
The association of alcohol consumption with the elevation of BP or increase in hypertension was confirmed in this middle-aged male Japanese occupational population. Means of systolic BP in the non-drinkers and chance drinkers seemed somewhat higher than that in the light drinkers, but the differences were not significant. On the other hand, means of diastolic BP and prevalence of hypertension showed increases in a linear manner with the increase in alcohol consumption. In addition, means of systolic BP increased in a linear manner when the comparison was made among the subjects divided by serum GGT levels. The dose-response pattern between alcohol consumption and BP in the present subjects was, therefore, considered to be a linear one, as has been often recognised in the studies in Japanese.
22,23
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The present study did not show marked differences in the alcohol and BP relationship among the different genotypes of ALDH2. Diastolic BP was suggested to be a little higher in the subjects having intact ALDH2, in contrast to the findings of Itoh et al 5 showing a higher BP in those inactive ALDH2. A higher BP in the drinkers with intact ALDH2 has also been observed in a previous study. 4 This has been considered to reflect under-reporting of alcohol consumption in people who can genetically drink more. No significant influence of ADH2 genotypes was observed on the relationship. Only a marginal effect of c2 allele of CYP2E1 on BP elevations was detected particularly in relatively larger volume alcohol consumers. The influences of the genotypes of ADH2 and CYP2E1 on alcohol-related BP elevation have not been fully investigated in Japanese populations except for our preliminary observation. 24 In the preliminary study, drinkers having c2/c2 genotype of CYP2E1 showed a significantly higher BP than the others when they consumed 90 ml or more of alcohol per day, which was basically in accordance with the present findings. However, the overall influence of the CYP2E1 gene on the alcohol and BP relationship in the Japanese population seems trivial even if it truly exists, because the proportion of c2/c2 genotype amounts to only 4% of the population. It is concluded therefore that the genetic differences in ethanol metabolizing enzymes in Japanese do not exert marked effects on the alcohol and BP relationship.
Once it is accepted that the genotypes of ALDH2 do not exert a large influence on the alcohol and BP relationship in Japanese, the interpretation of the findings of Itoh et al 5 in which drinkers manifesting facial flushing on alcohol consumption showed a higher prevalence of hypertension than those without becomes of great interest. One explanation could be the inconsistency between flushing response and the variant allele of ALDH2*2. Takeshita 25 reported that 10% of Japanese men having normal ALDH2 activity (ALDH2*1/1) experience facial flushing whenever they consume alcohol and 30% of them experience it sometimes, while 20% of those having ALDH2*1/2 genotype do not always experience facial flushing. The flushing response in drinkers thus may not necessarily correspond to the deficit in ALDH2 activity.
On the other hand, around 95% of Japanese have the allele of ADH2*2, which is quite rare in Caucasians. The enzyme of ADH2 consists of two subunit proteins and the 'atypical' ADH2 containing beta-2 subunit protein encoded from the ADH2*2 allele shows a 10 to 20-fold higher activity of converting ethanol to acetaldehyde than the 'typical' ADH2 consisting of two beta-1 proteins which are encoded from ADH2*1 allele. 1 Most Japanese thus may produce acetaldehyde in blood much more rapidly after drinking than Caucasians, and tend to show facial flushing with greater alcohol consumption even if they have normal ALDH2 activity. Therefore, the more frequent recognition of flushing response in hypertensive drinkers observed by Itoh et al 5 may have reflected their higher blood acetaldehyde caused by greater alcohol consumption but not by inactive ALDH2.
Although the present study showed that the genetic differences in ethanol metabolizing enzymes in Japanese do not greatly influence the alcohol to BP relationship, the possible pathogenic role of acetaldehyde in BP elevations remains to be elucidated. The pathogenesis of alcohol-induced hypertension as related to acetaldehyde has been proposed by Vasdev et al from the findings in experiments on rats fed ethanol water solution, namely, parallel elevations in BP and cytosolic-free calcium concentration in the platelets, 6, 7 and the prevention of those elevations by the administration of aldehyde absorbing substances. 8, 9 Vasdev et al speculated that BP in drinkers is elevated due to increased vascular smooth muscle tonus owing to the higher intracellular calcium caused by the effect of acetaldehyde on the cell-membrane calcium exchange. This hypothesis is quite attractive, but we should be very careful in extending such findings in rats fed ethanol water solution for 24 h, even as little as 5% ethanol, to human alcohol consumers showing hypertension due to a moderate volume of alcohol, around 60 ml or so, usually consumed only during a couple of hours in the evening or night. In addition, as far as we know, no significant association between the volume of alcohol consumed and cytosolic-free calcium concentrations in the platelets has been confirmed in the studies on human drinkers. 26, 27 A close association between serum GGT and BP in alcohol consumers was observed in the present study, and has been repeatedly shown in our previous studies [28] [29] [30] and in those of other researchers. 31, 32 It suggested an association between hepatic manifestations induced by alcohol, mainly steatosis in the liver, and BP elevation. 33 In the present subjects, serum GGT levels were also associated closely with elevations of erythrocyte Hb and MCV, and serum TG, Tch, HDLc and UA concentrations. These findings were in accordance with the report of Rantala et al 34 showing a close association between elevations of serum GGT and development of the metabolic syndrome in a Finnish population. Therefore, it is possible to assume that BP elevation in alcohol consumers is a manifestation of various metabolic alterations similar to those in the metabolic syndrome, related to the development of alcoholic hepatic steatosis, although this contention should be examined by further studies.
Acetaldehyde has been considered to play a major role in the development of alcoholic liver disease, 35 and thus it may also relate to the development of various metabolic alterations in drinkers including BP elevations. The higher BP in drinkers having c2 allele of CYP2E1 observed in our present and previous studies may have a relation to higher blood acetaldehyde. The c2 allele has been shown to
